10.67 USD
-0.21 (-1.93%)
10.67 USD
0 (0%)
CCRN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. CCRN has an excellent financial health rating, but there are some minor concerns on its profitability. CCRN has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
CCRN had positive earnings in the past year.
In the past year CCRN had a positive cash flow from operations.
In multiple years CCRN reported negative net income over the last 5 years.
Of the past 5 years CCRN 4 years had a positive operating cash flow.
1.2 Ratios
CCRN has a worse Return On Assets (-2.91%) than 61.39% of its industry peers.
CCRN has a Return On Equity of -3.84%. This is comparable to the rest of the industry: CCRN outperforms 48.51% of its industry peers.
CCRN's Return On Invested Capital of 0.98% is in line compared to the rest of the industry. CCRN outperforms 41.58% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CCRN is significantly above the industry average of 9.27%.
The 3 year average ROIC (15.05%) for CCRN is well above the current ROIC(0.98%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.91% | ||
| ROE | -3.84% | ||
| ROIC | 0.98% |
ROA(3y)9.37%
ROA(5y)8.5%
ROE(3y)17.7%
ROE(5y)17.81%
ROIC(3y)15.05%
ROIC(5y)13.58%
1.3 Margins
CCRN has a Operating Margin (0.56%) which is in line with its industry peers.
In the last couple of years the Operating Margin of CCRN has declined.
CCRN's Gross Margin of 20.19% is in line compared to the rest of the industry. CCRN outperforms 42.57% of its industry peers.
In the last couple of years the Gross Margin of CCRN has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.56% | ||
| PM (TTM) | N/A | ||
| GM | 20.19% |
OM growth 3Y-77.97%
OM growth 5Y-33.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y-3.83%
2. Health
2.1 Basic Checks
CCRN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for CCRN has been reduced compared to 1 year ago.
The number of shares outstanding for CCRN has been reduced compared to 5 years ago.
There is no outstanding debt for CCRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 4.75 indicates that CCRN is not in any danger for bankruptcy at the moment.
CCRN's Altman-Z score of 4.75 is amongst the best of the industry. CCRN outperforms 82.18% of its industry peers.
There is no outstanding debt for CCRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 4.75 |
ROIC/WACC0.11
WACC8.79%
2.3 Liquidity
A Current Ratio of 3.45 indicates that CCRN has no problem at all paying its short term obligations.
CCRN's Current ratio of 3.45 is amongst the best of the industry. CCRN outperforms 87.13% of its industry peers.
A Quick Ratio of 3.45 indicates that CCRN has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 3.45, CCRN belongs to the top of the industry, outperforming 89.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.45 | ||
| Quick Ratio | 3.45 |
3. Growth
3.1 Past
CCRN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -82.86%.
The Earnings Per Share has been growing by 24.57% on average over the past years. This is a very strong growth
The Revenue for CCRN has decreased by -22.14% in the past year. This is quite bad
The Revenue has been growing by 10.33% on average over the past years. This is quite good.
EPS 1Y (TTM)-82.86%
EPS 3Y-47.22%
EPS 5Y24.57%
EPS Q2Q%-75%
Revenue 1Y (TTM)-22.14%
Revenue growth 3Y-7.11%
Revenue growth 5Y10.33%
Sales Q2Q%-20.65%
3.2 Future
The Earnings Per Share is expected to decrease by -16.16% on average over the next years. This is quite bad
Based on estimates for the next years, CCRN will show a decrease in Revenue. The Revenue will decrease by -5.63% on average per year.
EPS Next Y-68.27%
EPS Next 2Y-23.6%
EPS Next 3Y-16.16%
EPS Next 5YN/A
Revenue Next Year-16.68%
Revenue Next 2Y-8.76%
Revenue Next 3Y-5.63%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
CCRN is valuated quite expensively with a Price/Earnings ratio of 88.92.
CCRN's Price/Earnings is on the same level as the industry average.
CCRN is valuated expensively when we compare the Price/Earnings ratio to 26.15, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 40.62 indicates a quite expensive valuation of CCRN.
The rest of the industry has a similar Price/Forward Earnings ratio as CCRN.
The average S&P500 Price/Forward Earnings ratio is at 36.12. CCRN is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 88.92 | ||
| Fwd PE | 40.62 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CCRN is valued a bit cheaper than the industry average as 72.28% of the companies are valued more expensively.
CCRN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CCRN is cheaper than 91.09% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.65 | ||
| EV/EBITDA | 10.61 |
4.3 Compensation for Growth
A cheap valuation may be justified as CCRN's earnings are expected to decrease with -16.16% in the coming years.
PEG (NY)N/A
PEG (5Y)3.62
EPS Next 2Y-23.6%
EPS Next 3Y-16.16%
5. Dividend
5.1 Amount
CCRN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
10.67
-0.21 (-1.93%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners98.83%
Inst Owner Change-0.6%
Ins Owners5.37%
Ins Owner Change-0.41%
Market Cap349.55M
Revenue(TTM)1.13B
Net Income(TTM)-15.68M
Analysts52.31
Price Target18.44 (72.82%)
Short Float %8.05%
Short Ratio6.34
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-69.09%
Min EPS beat(2)-118.38%
Max EPS beat(2)-19.79%
EPS beat(4)1
Avg EPS beat(4)-49.67%
Min EPS beat(4)-118.38%
Max EPS beat(4)5.59%
EPS beat(8)4
Avg EPS beat(8)-23.71%
EPS beat(12)7
Avg EPS beat(12)-12.92%
EPS beat(16)11
Avg EPS beat(16)-6.6%
Revenue beat(2)0
Avg Revenue beat(2)-8.46%
Min Revenue beat(2)-9.46%
Max Revenue beat(2)-7.46%
Revenue beat(4)0
Avg Revenue beat(4)-5.87%
Min Revenue beat(4)-9.46%
Max Revenue beat(4)-0.73%
Revenue beat(8)1
Avg Revenue beat(8)-3.08%
Revenue beat(12)3
Avg Revenue beat(12)-1.76%
Revenue beat(16)6
Avg Revenue beat(16)-0.91%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-12.91%
EPS NQ rev (3m)-12.91%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-4.3%
Revenue NQ rev (3m)-4.3%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 88.92 | ||
| Fwd PE | 40.62 | ||
| P/S | 0.31 | ||
| P/FCF | 7.65 | ||
| P/OCF | 6.44 | ||
| P/B | 0.86 | ||
| P/tB | 1.47 | ||
| EV/EBITDA | 10.61 |
EPS(TTM)0.12
EY1.12%
EPS(NY)0.26
Fwd EY2.46%
FCF(TTM)1.39
FCFY13.07%
OCF(TTM)1.66
OCFY15.52%
SpS34.42
BVpS12.46
TBVpS7.25
PEG (NY)N/A
PEG (5Y)3.62
Graham Number5.8
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.91% | ||
| ROE | -3.84% | ||
| ROCE | 1.39% | ||
| ROIC | 0.98% | ||
| ROICexc | 1.26% | ||
| ROICexgc | 2.43% | ||
| OM | 0.56% | ||
| PM (TTM) | N/A | ||
| GM | 20.19% | ||
| FCFM | 4.05% |
ROA(3y)9.37%
ROA(5y)8.5%
ROE(3y)17.7%
ROE(5y)17.81%
ROIC(3y)15.05%
ROIC(5y)13.58%
ROICexc(3y)15.28%
ROICexc(5y)13.73%
ROICexgc(3y)22.9%
ROICexgc(5y)20.79%
ROCE(3y)21.31%
ROCE(5y)19.23%
ROICexgc growth 3Y-75.41%
ROICexgc growth 5Y-32.32%
ROICexc growth 3Y-77.25%
ROICexc growth 5Y-30.83%
OM growth 3Y-77.97%
OM growth 5Y-33.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y-3.83%
F-Score5
Asset Turnover2.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 49.56% | ||
| Cap/Sales | 0.76% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 229.81% | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.45 | ||
| Quick Ratio | 3.45 | ||
| Altman-Z | 4.75 |
F-Score5
WACC8.79%
ROIC/WACC0.11
Cap/Depr(3y)64.63%
Cap/Depr(5y)60.57%
Cap/Sales(3y)0.55%
Cap/Sales(5y)0.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-82.86%
EPS 3Y-47.22%
EPS 5Y24.57%
EPS Q2Q%-75%
EPS Next Y-68.27%
EPS Next 2Y-23.6%
EPS Next 3Y-16.16%
EPS Next 5YN/A
Revenue 1Y (TTM)-22.14%
Revenue growth 3Y-7.11%
Revenue growth 5Y10.33%
Sales Q2Q%-20.65%
Revenue Next Year-16.68%
Revenue Next 2Y-8.76%
Revenue Next 3Y-5.63%
Revenue Next 5YN/A
EBIT growth 1Y-52.34%
EBIT growth 3Y-79.54%
EBIT growth 5Y-27.01%
EBIT Next Year540.8%
EBIT Next 3Y89.71%
EBIT Next 5YN/A
FCF growth 1Y-79.94%
FCF growth 3YN/A
FCF growth 5Y112.02%
OCF growth 1Y-77.47%
OCF growth 3YN/A
OCF growth 5Y85.29%
CROSS COUNTRY HEALTHCARE INC / CCRN FAQ
What is the ChartMill fundamental rating of CROSS COUNTRY HEALTHCARE INC (CCRN) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CCRN.
Can you provide the valuation status for CROSS COUNTRY HEALTHCARE INC?
ChartMill assigns a valuation rating of 3 / 10 to CROSS COUNTRY HEALTHCARE INC (CCRN). This can be considered as Overvalued.
Can you provide the profitability details for CROSS COUNTRY HEALTHCARE INC?
CROSS COUNTRY HEALTHCARE INC (CCRN) has a profitability rating of 4 / 10.
What is the financial health of CROSS COUNTRY HEALTHCARE INC (CCRN) stock?
The financial health rating of CROSS COUNTRY HEALTHCARE INC (CCRN) is 10 / 10.